Wells Fargo & Company »

Eledon Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Eledon Pharmaceuticals (ELDN) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Eledon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Eledon Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Eledon Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2025-09-30 $126k 49k 2.59
2025-06-30 $101k 37k 2.71
2024-03-31 $388 189 2.06
2023-12-31 $335 186 1.80
2023-09-30 $236 172 1.37
2023-06-30 $200 146 1.37
2022-12-31 $191 84 2.29
2022-09-30 $0 82 0.00
2022-06-30 $0 92 0.00
2022-03-31 $0 88 0.00
2021-12-31 $0 88 0.00
2021-09-30 $999 88 11.36
2021-06-30 $1.0k 92 10.87
2021-03-31 $1.0k 93 10.75